For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Conjuchem, Inc.

USPTO Granted Patents = 28

% Expired Patents = 42.9

Forward Citations = 1,261

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Dominique P Bridon (17 out of 26 patents)

Alan M Ezrin (16 out of 18 patents)

Darren L Holmes (14 out of 16 patents)

4. Peter G Milner (9 out of 41 patents)

5. Benoit L'Archeveque (8 out of 8 patents)

6. Anouk Leblanc (8 out of 8 patents)

7. Serge St Pierre (8 out of 9 patents)

8. Karen Thibaudeau (7 out of 13 patents)

9. Alexander Krantz (5 out of 27 patents)

10. Dominique Bridon (4 out of 13 patents)

11. Yonghong Song (3 out of 61 patents)

12. Martin Robitaille (3 out of 14 patents)

13. Nissab Boudjellab (3 out of 6 patents)

14. Wolin Huang (2 out of 26 patents)

15. Arthur M Hanel (2 out of 3 patents)

Core Competencies:

Exendin-4

Peptide Conjugates

Insulinotropic Peptides

Antinociceptive Agents

GLP-1

Thrombin Inhibitors

Anti-Angiogenic Peptides

Affinity Labeling

Gastrointestinal Diseases

Pain Alleviation

Viral Infection

Peptidase Activity

28 patents: Sort by Forward Citations

1. 8093206 - Methods involving long lasting synthetic exendin-4 peptide conjugates (2012-01-10),

2. 8084414 - Methods involving long lasting synthetic exendin-4-peptide conjugates (2011-12-27),

3. 8080516 - Long lasting synthetic exendin-4 peptide conjugates (2011-12-20),

4. 8039432 - Method of treatment of diabetes and/or obesity with reduced nausea side effect (2011-10-18),

5. 7982018 - Modified corticotropin releasing factor peptides and uses thereof (2011-07-19),

6. 7144854 - Long lasting anti-angiogenic peptides (2006-12-05),

7. 7112567 - Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders (2006-09-26),

8. 7090851 - Long lasting fusion peptide inhibitors of viral infection (2006-08-15),

9. 6887849 - Long lasting synthetic glucagon-like peptide {GLP-1} (2005-05-03),

10. 6887470 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-05-03),

11. 6849714 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2005-02-01),

12. 6821949 - Long lasting synthetic glucagon-like peptide (GLP-1) (2004-11-23),

13. 6706892 - Pulmonary delivery for bioconjugation (2004-03-16),

14. 6610825 - Method for alleviating pain or providing an analgesic effect in a patient (2003-08-26),

15. 6602981 - Antinociceptive agent derivative (2003-08-05),

Company Overview

Conjuchem, Inc. is a biotechnology company based in Montreal, Canada, specializing in the development of innovative therapeutic solutions. The company focuses on peptide-based drug delivery systems and advanced formulations, aiming to enhance the efficacy and safety of therapeutic agents. With a strong emphasis on research and development, Conjuchem leverages its expertise in biochemistry and pharmacology to address unmet medical needs, particularly in the fields of oncology and metabolic disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

28 Patents

#41 in Montreal

#504 in Canada

#23,299 in the World

Montreal, Canada

Conjuchem, Inc.

Forward Citations = 1,261

30 inventors:

Dominique P Bridon (17 out of 26 patents)

Alan M Ezrin (16 out of 18 patents)

Darren L Holmes (14 out of 16 patents)

4. Peter G Milner (9 out of 41 patents)

5. Benoit L'Archeveque (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Conjuchem, Inc.. Retrieved from https://idiyas.com/company/conjuchem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…